FREZYDERM S.A.
Premium PartnerIs this your company? Claim this profile
Drug Product
Regulatory, Tech Transfer & Support Services
Company Overview
About
FREZYDERM S.A. is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Gene Therapy, Cell Therapy, mRNA
Therapeutic Areas
Cardiovascular
Endocrinology
Quick Facts
HQ:Greece
Founded:1999
Employees:2,064
Capabilities & Services
Core Capabilities
- Sterile Injectable
- Sterile Fill/Finish
- Fill/Finish (Vials)
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Cartridge / Pen
Containment Capabilities
BSL-2 (Biosafety Level 2)
Production Scales
Pilot Scale
Clinical
Commercial Scale
Markets Served
Europe
Regulatory Approvals
Drug Approval Q3MGJY
PMDA · #APR-4ROQSH70 · 2022-11-01
Drug Approval YRAVXX
FDA · #APR-TYLOGRJY · 2021-09-01
Case Studies
0 published case studies showcasing past projects, challenges and outcomes.
Certifications
FDA Registration
U.S. Food and Drug Administration
Cert #: CERT-B05EG05H
Issued: 2020-12-01
Expires: 2025-01-21
EMA GMP Certificate
European Medicines Agency
Cert #: CERT-CDNPBP5D
Issued: 2020-02-13
Expires: 2025-06-14
WHO GMP
World Health Organization
Cert #: CERT-L7BDWXBH
Issued: 2020-05-13
Expires: 2025-03-27
Health Canada GMP
Health Canada
Cert #: CERT-NBTOKVHL
Issued: 2020-11-03
Expires: 2025-03-14
Loading CDMO intelligence...
Key facts about FREZYDERM S.A.
- FREZYDERM S.A. is headquartered in Greece.
- FREZYDERM S.A. was founded in 1999.
- FREZYDERM S.A. has 2,064 employees.
- FREZYDERM S.A.'s capabilities include Sterile Injectable, Sterile Fill/Finish and Fill/Finish (Vials).
Find CDMOs like FREZYDERM S.A.
Directory pages this company appears in, each with the full list of matching manufacturers.